What Attodiagnostics say about themselves
“AttoDiagnostics are a leading genetic testing company. We provide research and testing for brands, medical institutions and pharmacies to deliver life-changing personalised healthcare solutions.”
“AttoDiagnostics are a leading genetic testing company. We provide research and testing for brands, medical institutions and pharmacies to deliver life-changing personalised healthcare solutions.”
Not loaded yet. See them on Companies House
People and entities with significant control, from the Companies House PSC register
Balance sheet as at 31 March 2025 · micro entity accounts
| 2025 | 2024 | 2021 | 2020 | |
|---|---|---|---|---|
| Fixed Assets | £377,400 | £531,981 | £292,665 | £31,886 |
| Current Assets | £2,954,758 | £2,698,155 | £14,345,549 | £211,117 |
| Debtors | £2,560,778 | |||
| Cash | £24,303 | |||
| Creditors (< 1 year) | £350,968 | £388,375 | £3,762,332 | £246,162 |
| Creditors (> 1 year) | £1,334,135 | £50,000 | ||
| Net Current Assets | £2,603,790 | £2,309,780 | £10,583,217 | (£35,045) |
| Net Assets | £1,637,052 | £10,875,882 | (£53,159) | |
| Shareholder Funds | £1,637,052 | £2,841,761 | £10,875,882 | (£53,159) |
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 2 November 2026 | Statement of capital following an allotment of shares | |||
| 20 October 2026 | Sub-division of shares | |||
| 2 April 2026 | Confirmation statement with no updates | 31 March 2026 | ||
| 31 March 2026 | Micro company accounts | 31 March 2025 | ||
| 6 May 2025 | Satisfaction of a charge in full |
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →